Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The EU's reference laboratory for fish and crustacean diseases is to move from the UK to Denmark as the UK prepares to leave the bloc.
Zoetis has confirmed its plans to expand its global manufacturing and supply facility in Charles City, Iowa.
Netherlands-based company Bfactory International is heading to the UK and US with its Vetramil product line after a successful launch across several European markets during 2017.
US animal health distributor Patterson Companies has elected a corporate strategist and financial expert to its board of directors.
Austrian feed additive and diagnostic company Erber Group is creating a new hub for its North American business in Kansas City, Missouri.
The growing influence of Amazon and other online pet product retailers may result in some new sales strategies among the animal health majors.
Two US feed giants Archer Daniels Midland Company (ADM) and Cargill have reached an agreement to potentially build a large soy crush factory in north east Egypt.
Phibro Animal Health is experiencing a transition and gaining traction in new markets. Chief operating officer Larry Miller explains the company strategy to Animal Pharm analyst Malcolm Flanagan.
Mark Heffernan is to lead a new incubator designed to stimulate the crossover of technologies from human health into the veterinary medicines sector.
Spanish company CZ Veterinaria (CZV) is diversifying its business by moving into the stem cell therapy space and the companion animal vaccines area.
The chief executive of Spanish animal health firm Bionaturis believes its upcoming purchase of bioprocessing specialist ADL BioPharma will be transformational.
With Zoetis emerging from its restructuring project, the company is in its healthiest position since it was created five years ago. Animal Pharm editor Joseph Harvey spoke to Clint Lewis – the firm's executive vice president and president of international operations – about his thoughts on the business.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.